The government’s plan to introduce regulated abortion medication is renewing pressure on lawmakers to complete legal changes left unresolved after the Constitutional Court’s 2019 ruling on the abortion ban. Korean reporting says related revisions to criminal and maternal-health laws have remained unfinished even as officials move toward a medically supervised medication pathway.
The drug-approval process can advance separately, but a clearer statutory framework would define access, provider responsibilities and the wider rules surrounding abortion care.